Sunday, June 15th, 2025

Gamuda: Driving Infrastructure Growth with Robust Order Book and Strategic Expansion Plans

Date: October 2, 2024
Broker: UOB Kay Hian


Company Overview

Gamuda Berhad (GAM) is a leading infrastructure and property development company in Malaysia, recognized for its robust project execution capabilities and strong order book.

Market Position

  • Strong Order Book: Gamuda has maintained a sturdy order book, positioning itself well to capitalize on the growing demand for infrastructure development in Malaysia and the region.

Strategic Developments

  • Robust Earnings Growth: The company is anticipated to experience significant earnings growth, supported by a solid order book and a favorable replenishment outlook for future projects. This growth is underpinned by ongoing infrastructure projects, which are critical for Malaysia’s economic development.

Financial Performance

  • Recent Performance: Gamuda has demonstrated resilience in its financial performance, with key projects contributing positively to its revenue and earnings. The company’s strategic initiatives are expected to enhance profitability in the coming quarters.

Future Outlook

  • Bright Prospects: With a strong pipeline of projects and an emphasis on strategic expansion, Gamuda is well-positioned to drive further growth in the infrastructure sector. The company’s commitment to innovation and efficiency will play a crucial role in maintaining its competitive edge.

Investment Recommendation

  • Buy Rating: Maintain a BUY recommendation, reflecting confidence in Gamuda’s strategic direction and potential for robust long-term returns driven by infrastructure investments and development activities.

Centurion Corp (CENT SP) Stock Analysis: REIT Listing, Revenue Growth, and OUTPERFORM Rating (April 2025)

KGI Securities (Singapore) Pte. Ltd. April 11, 2025 Centurion Corp Ltd: REIT Listing Exploration and Strong Growth Trajectory Company Overview Centurion Corp Ltd (CENT SP/OU8.SI) is exploring a potential REIT structure comprising stabilized Purpose-Built...

Anteris Technologies IPO: A Game-Changer in Heart Valves, Oversubscribed by 9x

1. IPO Details Purpose of IPO: Anteris Technologies plans to use IPO proceeds to advance R&D for its flagship DurAVR transcatheter heart valve, expand production facilities, and boost global commercialization. Approximately $100 million of...

SATS Q2 Earnings Beat: Strong Growth and Ambitious FY29 Targets Signal Promising Future

SATS Ltd: A Comprehensive Financial Analysis SATS Ltd: A Comprehensive Financial Analysis Broker: UOB Kay Hian Date of Report: Monday, 11 November 2024 Company Overview SATS Ltd is a leading food solutions provider in...